• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.快速指南的制定:2. 与世界卫生组织指南制定者进行的定性研究。
Health Res Policy Syst. 2018 Jul 13;16(1):62. doi: 10.1186/s12961-018-0329-6.
2
Development of rapid guidelines: 1. Systematic survey of current practices and methods.快速指南的制定:1. 对当前实践和方法的系统调查。
Health Res Policy Syst. 2018 Jul 13;16(1):61. doi: 10.1186/s12961-018-0327-8.
3
Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations.快速指南的制定:3. 用于快速推荐的 GIN-McMaster 指南制定清单扩展。
Health Res Policy Syst. 2018 Jul 13;16(1):63. doi: 10.1186/s12961-018-0330-0.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
How to develop cost-conscious guidelines.如何制定注重成本的指南。
Health Technol Assess. 2001;5(16):1-69. doi: 10.3310/hta5160.
6
Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.将成本效益、可负担性和资源影响因素纳入指南制定中:COPD 指南制定中整合和协调工作的第 6 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):251-5. doi: 10.1513/pats.201208-059ST.
7
Disseminating and implementing guidelines: article 13 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.推广和实施指南:COPD 指南制定中整合和协调工作的第 13 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):298-303. doi: 10.1513/pats.201208-066ST.
8
Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.从证据到指南推荐意见的制定:COPD 指南制定中整合和协调工作的第 11 条。美国胸科学会/欧洲呼吸学会官方工作组报告。
Proc Am Thorac Soc. 2012 Dec;9(5):282-92. doi: 10.1513/pats.201208-064ST.
9
Qualitative Evidence Synthesis (QES) for Guidelines: Paper 3 - Using qualitative evidence syntheses to develop implementation considerations and inform implementation processes.定性证据综合 (QES) 指南:第 3 篇——利用定性证据综合来制定实施注意事项并为实施过程提供信息。
Health Res Policy Syst. 2019 Aug 8;17(1):74. doi: 10.1186/s12961-019-0450-1.
10
National stakeholders' perceptions of the processes that inform the development of national clinical practice guidelines for primary healthcare in South Africa.国家利益相关者对南非基层医疗国家临床实践指南制定过程的看法。
Health Res Policy Syst. 2018 Jul 31;16(1):68. doi: 10.1186/s12961-018-0348-3.

引用本文的文献

1
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.2020 - 2022年用于治疗妊娠期COVID - 19药物的国家指南演变:一项范围综述
J Clin Med. 2023 Jul 6;12(13):4519. doi: 10.3390/jcm12134519.
2
The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development.用于在指南中整合质量改进和质量保证的 GIN-McMaster 指南工具扩展:其开发方法的描述。
J Clin Epidemiol. 2023 Feb;154:197-203. doi: 10.1016/j.jclinepi.2022.04.002. Epub 2022 Apr 15.
3
Methodology and experiences of rapid advice guideline development for children with COVID-19: responding to the COVID-19 outbreak quickly and efficiently.COVID-19 患儿快速咨询指南制定的方法和经验:快速高效应对 COVID-19 疫情。
BMC Med Res Methodol. 2022 Apr 3;22(1):89. doi: 10.1186/s12874-022-01545-5.
4
International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review.国际联盟和 71 项关于 COVID-19 重症监护患者管理的临床实践指南的 AGREE 协议:一项实时系统评价。
J Clin Epidemiol. 2022 Feb;142:333-370. doi: 10.1016/j.jclinepi.2021.11.010. Epub 2021 Nov 14.
5
Guidelines developed under pressure. The case of the COVID-19 low-quality "rapid" guidelines and potential solutions.在压力下制定的指南。COVID-19低质量“快速”指南的情况及潜在解决方案。
J Clin Epidemiol. 2022 Feb;142:194-199. doi: 10.1016/j.jclinepi.2021.11.012. Epub 2021 Nov 13.
6
Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group.在公共卫生指南和系统评价中应用 GRADE 方法的挑战:来自 GRADE 公共卫生组的概念文章。
J Clin Epidemiol. 2021 Jul;135:42-53. doi: 10.1016/j.jclinepi.2021.01.001. Epub 2021 Jan 18.
7
Advancing the WHO-INTEGRATE Framework as a Tool for Evidence-Informed, Deliberative Decision-Making Processes: Exploring the Views of Developers and Users of WHO Guidelines.推进世卫组织综合框架作为循证决策过程的工具:探索世卫组织指南制定者和使用者的观点。
Int J Health Policy Manag. 2022 May 1;11(5):629-641. doi: 10.34172/ijhpm.2020.193.
8
Developing trustworthy recommendations as part of an urgent response (1-2 weeks): a GRADE concept paper.作为紧急响应的一部分制定可信推荐(1-2 周):一个 GRADE 概念文件。
J Clin Epidemiol. 2021 Jan;129:1-11. doi: 10.1016/j.jclinepi.2020.09.037. Epub 2020 Sep 30.
9
Development of rapid guidelines: 1. Systematic survey of current practices and methods.快速指南的制定:1. 对当前实践和方法的系统调查。
Health Res Policy Syst. 2018 Jul 13;16(1):61. doi: 10.1186/s12961-018-0327-8.

本文引用的文献

1
Development of rapid guidelines: 1. Systematic survey of current practices and methods.快速指南的制定:1. 对当前实践和方法的系统调查。
Health Res Policy Syst. 2018 Jul 13;16(1):61. doi: 10.1186/s12961-018-0327-8.
2
Using GRADE to respond to health questions with different levels of urgency.使用 GRADE 对不同紧急程度的健康问题进行回应。
Environ Int. 2016 Jul-Aug;92-93:585-9. doi: 10.1016/j.envint.2016.03.027. Epub 2016 Apr 26.
3
Reviews: Rapid! Rapid! Rapid! …and systematic.综述:迅速!迅速!迅速!……且系统。
Syst Rev. 2015 Jan 14;4(1):4. doi: 10.1186/2046-4053-4-4.
4
Standards for reporting qualitative research: a synthesis of recommendations.报告定性研究的标准:建议的综合。
Acad Med. 2014 Sep;89(9):1245-51. doi: 10.1097/ACM.0000000000000388.
5
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.指南 2.0:成功指南企业的全面清单系统开发。
CMAJ. 2014 Feb 18;186(3):E123-42. doi: 10.1503/cmaj.131237. Epub 2013 Dec 16.
6
Evidence summaries: the evolution of a rapid review approach.证据总结:快速综述方法的演变。
Syst Rev. 2012 Feb 10;1:10. doi: 10.1186/2046-4053-1-10.
7
Expediting systematic reviews: methods and implications of rapid reviews.加速系统评价:快速综述的方法和意义。
Implement Sci. 2010 Jul 19;5:56. doi: 10.1186/1748-5908-5-56.
8
AGREE II: advancing guideline development, reporting and evaluation in health care.《AGREE II:推进卫生保健领域的指南制定、报告与评估》
CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5.
9
What's in a name? Qualitative description revisited.名称的含义是什么?重新审视定性描述。
Res Nurs Health. 2010 Feb;33(1):77-84. doi: 10.1002/nur.20362.
10
Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment.快速综述与全面系统综述:卫生技术评估中当前方法与实践的汇总
Int J Technol Assess Health Care. 2008 Spring;24(2):133-9. doi: 10.1017/S0266462308080185.

快速指南的制定:2. 与世界卫生组织指南制定者进行的定性研究。

Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.

机构信息

Department of Health Research Methods, Evidence and Impact and Mac GRADE Center, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.

Department of Pediatrics, University of Antioquia, Cra. 51D #62-29, Medellin, 050001, Colombia.

出版信息

Health Res Policy Syst. 2018 Jul 13;16(1):62. doi: 10.1186/s12961-018-0329-6.

DOI:10.1186/s12961-018-0329-6
PMID:30005710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6044000/
Abstract

BACKGROUND

Situations such as public health emergencies and outbreaks necessitate the development and publication of high-quality recommendations within a condensed timeframe. For example, WHO has produced examples of and guidance for the development of rapid guidelines (RGs). However, more information is needed to understand the experiences and perceptions of guideline developers. This is the second of a series of three articles addressing methodological issues around RGs. This study describes the perceptions and experiences of guideline developers at WHO about RGs.

METHODS

We conducted interviews consisting of open- and closed-ended questions with guideline developers at WHO. Our analysis described the definition and rationale of RGs, the differences from regular guidelines with regard to timelines from topic definition until publication, barriers to identifying the evidence and the lack of a standard methodology to develop RGs.

RESULTS

We interviewed 10 participants, the majority of whom were comfortable with the current WHO definition of RGs. Most stated that the rationale for developing RGs should be in response to new evidence about efficacy, cost-effectiveness or safety. Respondents differed with regards to the amount of time RGs should take. While the majority of participants agreed that guidelines should be based on a systematic review, this step in the process was considered the most time and resource intensive. Challenges for developing RGs included limited personnel and financial resources as well as the lack of evidence. Facilitators, in turn, that may improve RG development include additional financial and personnel resources as well as the use of virtual meetings.

CONCLUSIONS

While our study suggests a strong need and rationale for the development of RGs, standardisation of timelines and guidance on panel composition, peer-review process, conduct of meetings and sources of permissible evidence require further research.

摘要

背景

公共卫生突发事件和疫情等情况需要在短时间内制定和发布高质量的建议。例如,世卫组织已经制定了快速指南(RGs)的范例和指南。然而,为了更好地了解指南制定者的经验和看法,还需要更多的信息。这是三篇关于 RG 方法问题的系列文章中的第二篇。本研究描述了世卫组织指南制定者对 RG 的看法和经验。

方法

我们与世卫组织的指南制定者进行了包含开放式和封闭式问题的访谈。我们的分析描述了 RG 的定义和基本原理、与常规指南在从主题定义到出版的时间线上的差异、确定证据的障碍以及缺乏制定 RG 的标准方法。

结果

我们采访了 10 名参与者,他们中的大多数人对世卫组织目前对 RG 的定义感到满意。大多数人表示,制定 RG 的理由应该是针对疗效、成本效益或安全性方面的新证据。受访者对 RG 所需的时间长短存在分歧。虽然大多数参与者都同意指南应该基于系统评价,但这一过程步骤被认为是最耗费时间和资源的。制定 RG 的挑战包括人员和财务资源有限以及证据不足。反过来,有助于 RG 开发的因素包括增加财务和人员资源以及使用虚拟会议。

结论

尽管我们的研究表明需要强烈制定 RG,并且制定 RG 的时间表和小组组成、同行评审流程、会议进行方式和允许证据来源的指导方针需要进一步研究。